INVO Fertility (IVF) CFO reports Form 3 insider option grants

Rhea-AI Filing Summary

INVO Fertility, Inc. reported the initial holdings of its Chief Financial Officer, Terah Renee Krigsvold, as of 12/30/2025 on a Form 3. She directly holds 1 share of common stock and a series of stock options giving the right to purchase additional common shares.

The disclosed stock options cover small numbers of underlying common shares, including grants for 3, 3, 2, 2, 2, 11 and 4,375 shares, with stated exercise prices such as $17,683.2, $17,280, $2,304, $2,983.68, $3,882.24, $2,119.68 and $8.96. Footnotes explain that several options have vesting schedules based on monthly installments over 36 months or quarterly installments beginning in 2023 and, for the latest grant, on the first day of calendar quarters following August 26, 2025.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Krigsvold Terah Renee

(Last) (First) (Middle)

C/O INVO FERTILITY, INC.

5582 BROADCAST COURT

(Street)

SARASOTA FL 34240

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/30/2025

3. Issuer Name and Ticker or Trading Symbol
INVO Fertility, Inc. [ IVF ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	01/03/2031	Common Stock	3	$17,683.2	D
Stock Option (right to buy)	(2)	02/10/2032	Common Stock	3	$17,280	D
Stock Option (right to buy)	12/29/2022	12/28/2032	Common Stock	2	$2,304	D
Stock Option (right to buy)	01/13/2023	01/12/2033	Common Stock	2	$2,983.68	D
Stock Option (right to buy)	01/31/2023	01/30/2033	Common Stock	2	$3,882.24	D
Stock Option (right to buy)	(3)	05/17/2033	Common Stock	11	$2,119.68	D
Stock Option (right to buy)	(4)	08/25/2035	Common Stock	4,375	$8.96	D

Explanation of Responses:

1. The option vested in monthly increments over a period of 36 months from January 1, 2021.

2. The option vested in monthly increments over a period of 36 months from February 11, 2022.

3. The option vests in 12 equal installments beginning on May 18, 2023 and on the last day of each calendar quarter thereafter until fully vested.

4. The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.

	/s/ Terah Krigsvold	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does this Form 3 filing for INVO Fertility (IVF) show?

It shows the initial statement of beneficial ownership for Chief Financial Officer Terah Renee Krigsvold as of 12/30/2025, including her common stock and stock option holdings in INVO Fertility, Inc..

How many INVO Fertility common shares does the CFO directly own?

The filing reports that the CFO directly owns 1 share of common stock of INVO Fertility, Inc..

What stock options are reported for the INVO Fertility CFO on this Form 3?

The Form 3 lists several stock options (rights to buy common stock) covering 3, 3, 2, 2, 2, 11 and 4,375 underlying shares, each reported as held directly.

What are the exercise prices of the INVO Fertility CFO’s stock options?

The options have reported exercise prices including $17,683.2, $17,280, $2,304, $2,983.68, $3,882.24, $2,119.68 and $8.96 for the various grants.

How do the INVO Fertility CFO’s stock options vest?

Footnotes state that some options vested in monthly increments over 36 months starting January 1, 2021 or February 11, 2022, while others vest in 12 equal quarterly installments beginning May 18, 2023 or in four equal quarterly installments starting on the first day of the calendar quarter after August 26, 2025.

Is the INVO Fertility CFO’s ownership direct or through another entity?

The Form 3 marks all reported holdings, including the 1 common share and all listed stock options, as held directly (D), with no separate indirect ownership entity noted.